Archived News for Health Sector Professionals - September, 2015
Sexual problems are often an unspoken side-effect for the 3.72 million Australians living with cardiovascular disease, but one expert wants to lift the lid.
The well-publicised hike in the price of an essential medicine this week raises serious issues about the design of the Trans-Pacific Partnership (TPP), an intellectual property expert has warned.
The Australians behind vital and exciting research combating conditions like cancer, depression and birth defects will be recognised at a prestigious awards ceremony this week.
Fourteen years ago, GlaxoSmithKline published a study claiming the antidepressant paroxetine was safe and effective for teenagers, but now researchers say the opposite is true.
Smoggy, polluted and otherwise dirty air is well known to carry some serious health risks, but Australian scientists have for the first time got a glimpse of what might be happening at the molecular level.
New stats suggest that over a quarter of hospitalisations of older Australians could be caused by poor medication-related primary care before admission – costing the Australian health system $300 million a year.